Democracy IO is an open soruce free application that will do most of the heavy listing associated to letting your elected federal representatives know how you feel about preserving and protecting your access to the personal importation of non-controlled prescription drugs from licensed foreign pharmacies.
Put in some basic information, write your letter (or paste in the one I drafted below, edited if you choose) and it will address and send separate email letters in the format your officials require.
Please feel free to use and adapt the letter below to meet your needs. I do think it important that they receive these letters within the next few days. One branch of the government is spreading information that this is to prevent the importation is illegal narcotics. Of course, that is not true and the new policy will have lieele or no effect on those illegal and harmful activities.
LETTER TO ELECTED OFFICIALS
Honorable [Senator / Representative] [Name], (democracy.io will affix the headings)
I am writing as your constituent to ask you to act before October 22, 2026. On that date, new Customs and Border Protection procedures for international mail could cut off a long-standing lifeline for Americans who cannot afford their medications at U.S. prices.
I support efforts to stop counterfeit and dangerous drugs. But a genuine, non-controlled medicine, prescribed by a U.S. clinician, dispensed by a licensed pharmacy abroad, and shipped in a personal-use quantity, is not that threat.
An estimated 2.3 million U.S. adults buy prescription drugs from outside the United States each year to save money. The savings are not marginal. One patient reported paying $35 for a type 2 diabetes medication through international mail order, against $1,600 in the United States. A 79-year-old Connecticut man told reporters that a heart and lung medication costing him about $17 a month would run roughly $500 to $600 if bought domestically. Even after new duties and customs costs, prices abroad often remain a fraction of U.S. prices. For patients on anticoagulants, cardiac medications, or diabetes therapies, that difference can decide whether they take their medicine as prescribed or ration it. Some of those choices are life-or-death.
The new CBP rule does not ban personal importation. Its effect is to route every medicine parcel through formal customs entry, with bonds and filing requirements built for commercial importers. Advocates warn that if private logistics firms screen shipments against restrictive readings of FDA criteria before the packages reach FDA, patients could lose medicines the agency itself would have allowed under its long-standing enforcement discretion.
In appreciation of the above, I ask you to:
Support the bipartisan call for a delay. Seventy-one House members have asked HHS, FDA, DHS, and CBP to delay the new procedures for prescription medicines until the agencies give clear assurances that personal-use medicines will not be blocked.
Introduce or cosponsor legislation that codifies personal importation of non-controlled prescription drugs from licensed foreign pharmacies, with a valid U.S. prescription, up to a 90-day supply.
Direct CBP and FDA to create a simple, low-cost entry pathway for these shipments, without commercial bonding requirements. The law should also guarantee that FDA, not a private intermediary, decides whether a shipment is admitted.
Americans should not have to choose between their health and their savings.
Please act before October 22.
Sincerely,
[Name]
[Credentials, if applicable]
[Street address, City, State, ZIP]